New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Updated guidelines issued for management of anaphylaxis

Updated guidelines issued for management of anaphylaxis

by Elana GotkineIn a practice parameter update published online Dec. 17 in theAnnals of Allergy, Asthma & Immunology, new guidelines are presented for the diagnosis and management of anaphyl
Immunology & Rheumatology January 25,2024
Updated guidelines issued for management of anaphylaxis

Updated guidelines issued for management of anaphylaxis

by Elana GotkineIn a practice parameter update published online Dec. 17 in theAnnals of Allergy, Asthma & Immunology, new guidelines are presented for the diagnosis and management of anaphyl
Immunology & Rheumatology January 25,2024
Researchers investigate why vaccines don't work as well in some older adults

Researchers investigate why vaccines don't work as well in some older adults

by Mark Wanner,University of ConnecticutFunctional antibody response to PCV13 and PPSV23 in older adults. Credit:Nature Immunology(2024). DOI: 10.1038/s41590-023-01717-5An important
Public Health & Prevention January 25,2024
Researchers investigate why vaccines don't work as well in some older adults

Researchers investigate why vaccines don't work as well in some older adults

by Mark Wanner,University of ConnecticutFunctional antibody response to PCV13 and PPSV23 in older adults. Credit:Nature Immunology(2024). DOI: 10.1038/s41590-023-01717-5An important
Public Health & Prevention January 25,2024
FDA approves mirikizumab, a promising induction and maintenance therapy for ulcerative colitis

FDA approves mirikizumab, a promising induction and maintenance therapy for ulcerative colitis

byThe Mount Sinai HospitalEndoscopic image of a bowel section known as the sigmoid colon afflicted with ulcerative colitis. The internal surface of the colon is blotchy and broken in places. Cre
Gastroenterology January 25,2024
FDA approves mirikizumab, a promising induction and maintenance therapy for ulcerative colitis

FDA approves mirikizumab, a promising induction and maintenance therapy for ulcerative colitis

byThe Mount Sinai HospitalEndoscopic image of a bowel section known as the sigmoid colon afflicted with ulcerative colitis. The internal surface of the colon is blotchy and broken in places. Cre
Gastroenterology January 25,2024
New hope for patients with non-alcoholic fatty liver disease

New hope for patients with non-alcoholic fatty liver disease

byUniversity of MontrealCredit:Metabolism(2023). DOI: 10.1016/j.metabol.2023.155736Non-alcoholic fatty liver disease (NAFLD) is a major health problem affecting approximately 30% of
Hepatobiliary&Pancreas Surgery January 25,2024
New hope for patients with non-alcoholic fatty liver disease

New hope for patients with non-alcoholic fatty liver disease

byUniversity of MontrealCredit:Metabolism(2023). DOI: 10.1016/j.metabol.2023.155736Non-alcoholic fatty liver disease (NAFLD) is a major health problem affecting approximately 30% of
Hepatobiliary&Pancreas Surgery January 25,2024
How liver cells become scarring, and worse

How liver cells become scarring, and worse

by Sanford-Burnham PrebysIn this stained micrograph, strands of activated hepatic stellate cells (blue) create characteristic “chicken wire” fibrosis in the liver and, in this case, a condition called
Hepatobiliary&Pancreas Surgery January 25,2024
How liver cells become scarring, and worse

How liver cells become scarring, and worse

by Sanford-Burnham PrebysIn this stained micrograph, strands of activated hepatic stellate cells (blue) create characteristic “chicken wire” fibrosis in the liver and, in this case, a condition called
Hepatobiliary&Pancreas Surgery January 25,2024
Eating beans found to improve gut health, regulate immune and inflammatory processes in colorectal cancer survivors

Eating beans found to improve gut health, regulate immune and inflammatory processes in colorectal cancer survivors

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainIncorporating navy beans into the diet of colorectal cancer (CRC) survivors has the potential to positively imp
Gastroenterology January 25,2024
Eating beans found to improve gut health, regulate immune and inflammatory processes in colorectal cancer survivors

Eating beans found to improve gut health, regulate immune and inflammatory processes in colorectal cancer survivors

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainIncorporating navy beans into the diet of colorectal cancer (CRC) survivors has the potential to positively imp
Gastroenterology January 25,2024
Investigating new and future therapies for managing inflammatory bowel disease

Investigating new and future therapies for managing inflammatory bowel disease

by First Hospital of Jilin UniversityAntitumour necrosis factor alpha (anti-TNFα) agents include infliximab, adalimumab, golimumab, AVX-470 and OPRX-106. Janus kinase (JAK) inhibitors: tofacitinib, fi
Gastroenterology January 25,2024
Investigating new and future therapies for managing inflammatory bowel disease

Investigating new and future therapies for managing inflammatory bowel disease

by First Hospital of Jilin UniversityAntitumour necrosis factor alpha (anti-TNFα) agents include infliximab, adalimumab, golimumab, AVX-470 and OPRX-106. Janus kinase (JAK) inhibitors: tofacitinib, fi
Gastroenterology January 25,2024
First comprehensive guideline on using biomarkers for monitoring Crohn's disease

First comprehensive guideline on using biomarkers for monitoring Crohn's disease

byAmerican Gastroenterological AssociationHigh magnification micrograph of Crohn's disease. Biopsy of esophagus. H&E stain. Credit: Nephron/WikipediaThe American Gastroenterological Asso
Gastroenterology January 25,2024
First comprehensive guideline on using biomarkers for monitoring Crohn's disease

First comprehensive guideline on using biomarkers for monitoring Crohn's disease

byAmerican Gastroenterological AssociationHigh magnification micrograph of Crohn's disease. Biopsy of esophagus. H&E stain. Credit: Nephron/WikipediaThe American Gastroenterological Asso
Gastroenterology January 25,2024
Unveiling a novel immune response in the intestinal epithelium

Unveiling a novel immune response in the intestinal epithelium

byCharles UniversityImmune response to SFB bacteria in the intestines. Credit: Katarína KováčováResearchers from the Jan Dobeš laboratory at Charles University in Prague have made a significant
Gastroenterology January 25,2024
Unveiling a novel immune response in the intestinal epithelium

Unveiling a novel immune response in the intestinal epithelium

byCharles UniversityImmune response to SFB bacteria in the intestines. Credit: Katarína KováčováResearchers from the Jan Dobeš laboratory at Charles University in Prague have made a significant
Gastroenterology January 25,2024
Cholesterol-lowering therapy may hinder aggressive type of colorectal tumor

Cholesterol-lowering therapy may hinder aggressive type of colorectal tumor

byWeill Cornell Medical CollegeMultiplex immunofluorescence image of cholesterol-rich human serrated colorectal cancer. Highly aggressive tumoral cells (green and magenta) are negative for both
Gastroenterology January 25,2024
Cholesterol-lowering therapy may hinder aggressive type of colorectal tumor

Cholesterol-lowering therapy may hinder aggressive type of colorectal tumor

byWeill Cornell Medical CollegeMultiplex immunofluorescence image of cholesterol-rich human serrated colorectal cancer. Highly aggressive tumoral cells (green and magenta) are negative for both
Gastroenterology January 25,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com